Cite Filings / CMPX / 0001140361-26-017650

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Compass Therapeutics, Inc. Filed 2026-04-29 Acc 0001140361-26-017650

Documents 1

DEFA14A Proxy Materials , edge20068103x2_defa14a.htm

Around this filing

2026-04-30 4/A Chief Accounting Officer bought 15,000 shares at $1.89 ($28,350)
2026-04-29 4 General Counsel acquired 25,000 shares (grant or award)
2026-04-29 4 Chief Accounting Officer acquired 15,000 shares (grant or award)
2026-04-29 ARS Annual Report to Security Holders
2026-04-29 DEFA14A Proxy Materials
2026-04-29 DEF 14A Proxy Statement
2025-04-29 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading edge20068103x2_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…